SC Daily- ASYI Is a Game Changer
Having trouble viewing this email Click here http://campaign.constantcontact.com/renderv0015U2tEoPRVkg-7f3giHRukxcqh-8u2Xj2DDTiiKxsa6Qh6j0FXJyy8Hq-yWcg-TPpwYRg4x33DJ-4_5jTQwCRpsYHP1Hdczk02IbMMQanDTdrEkkp0na-nQ%3D%3D 6-7-10 Small Cap Daily by SmallCapVoice.com ———————————— Yesterday`s Top Performers ———————————— Company: Tie Technologies, Inc. (Pink Sheets: TTCS) End of day:
Price: 0.30 Change (%): + 0.05 (20.00) Volume: 36,122 http://bit.ly/9KeCUD ————————— Hot Stocks To Watch ————————— Company: AISystems, Inc. (OTCBB: ASYI) End of day:
Price: 0.50 Change (%): + 0.02 (4.17) Volume: 204,139 http://bit.ly/ddBy0g AISystems Announces Revolutionary Crew Scheduling and Rostering Technology KIRKLAND, Wash., June 7, 2010 (GLOBE NEWSWIRE) AISystems, Inc. (OTCBB:ASYI) (AISystems or the Company), a technology leader in the development of business platform software for the airline industry, announced today that its revolutionary crew scheduling and rostering technology will be released in 2011.
Read More >> http://bit.ly/9hMW20 ————————————- SmallCapVoice Clients` News ————————————- Company: BRAVADA International Ltd (Pink SHeets: MFLI) http://bit.ly/dpXWMg BRAVADA Muscle Flex Announces Special Guest Denise Richards to Attend its Exclusive Red Carpet BRAVADA Women`s Athletica Grand Opening Party on June 10 on Robertson Blvd in Los Angeles Jun. 7, 2010 (Business Wire) BRAVADA Muscle Flex Inc. (www.BravadaLtd.com) (Pink Sheets:MFLI) announced today that special guest Denise Richards to attend BRAVADAs Red Carpet Grand Opening Party for the BRAVADA Womens Athletica Los Angeles Robertson Blvd Retail location. Denise Richards (www.DeniseRichards.com) is one of the Worlds most recognized and respected female personalities and her accomplishments transcend across movies, television and fashion. As BRAVADAs special guests, Denise Richards brings incredible excitement in joining the celebration for the BRAVADA Womens Athletica Store Grand Opening extravaganza being held on June 10 at 322 Robertson Blvd in Los Angeles California.
Read More >> http://bit.ly/bqtqQi —————————– Other Small Cap News —————————– Company: Sucampo Pharmaceuticals, Inc. (Nasdaq: SCMP) http://bit.ly/bmtkYw R-Tech Ueno Discloses Results of Phase 2 Retinitis Pigmentosa Clinical Trial BETHESDA, Md.–(BUSINESS WIRE)–Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today confirmed that its partner, R-Tech Ueno, Ltd. (RTU) (Osaka Securities Exchange Hercules code: 4573), reported the results of its recently completed phase 2 clinical trial of UF-021 in retinitis pigmentosa patients. The results showed improvement in visual function dose-dependently in both visual field test and subjective findings. Furthermore, although there was an irritation upon instillation, there were no severe adverse effects.
Read More >> http://yhoo.it/c4Omic ————————————————————– Company: MAG Silver Corp. (NYSE Amex: MVG) http://bit.ly/ab4qEi MAG Silver Intercepts More Molybdenum-Gold at Pozo Seco and New Intercepts of Zinc-Lead-Copper-Silver-Gold 0.052% Molybdenum Over 164.86 Metres (532.50 Feet) and 0.10% Molybdenum Over 94.03 Metres (303.72 Feet) VANCOUVER, BRITISH COLUMBIA–(Marketwire – 06/04/10) – MAG Silver Corp. (TSX:MAG)(AMEX:MVG) (“MAG”) announces additional gold and molybdenum (“moly”) assay results from on-going drilling (17 diamond drill holes) of the Pozo Seco moly-gold discovery on its 100% owned Cinco de Mayo (or “Cinco”) property in northern Chihuahua State, Mexico. Results confirm that Pozo Seco not only represents an emerging moly deposit target in its own right, but also represents an important indicator of nearby significant lead-zinc-silver mineralization typical of the Carbonate Replacement Deposits (CRDs) in this part of Mexico.
Read More >> http://yhoo.it/balDW3 ——————————————————————- Company: Allied Motion Technologies Inc. (Nasdaq: AMOT) http://bit.ly/9pXtoa Allied Motion Announces Acquisition of Agile Systems Inc.
DENVER–(BUSINESS WIRE)–Allied Motion Technologies Inc. (NASDAQ: AMOT) today announced it has completed the purchase of Agile Systems Inc. (Agile), a privately owned Canadian corporation. Allied purchased the shares of Agile and the purchase price was paid in cash at closing. Agile was founded in 1994 and is a leader in the design and development of advanced motion control technology including integrated power electronics, digital controls and network communications for motor control and power conversion.
Read More >> http://yhoo.it/9o7dHM ————————————————————————— Company: TomoTherapy Incorporated (Nasdaq: TOMO) http://bit.ly/bv2ULU TomoTherapy to Present at Annual Needham Healthcare Conference MADISON, WI–(Marketwire – 06/04/10) – TomoTherapy Incorporated (NASDAQ:TOMO), maker of advanced radiation therapy solutions for cancer care, today announced that CFO Thomas Powell and Vice President of Marketing Del Coufal will present at the 9th Annual Needham Healthcare Conference on Thursday, June 10, 2010 at 11:20 a.m. ET. The conference is scheduled for June 9-10 at The New York Palace Hotel in New York City, N.Y.
Read More >> http://yhoo.it/9tnr0G ————————————————————————– Company: Myriad Pharmaceuticals, Inc. (Nasdaq: MYRX) http://bit.ly/cYRvyn Myriad Pharmaceuticals Announces Presentations of Phase 2 Data of Azixa(TM) Demonstrating Durable Responses in Patients With Glioblastoma Multiforme and Metastatic Melanoma at ASCO 2010 SALT LAKE CITY, June 7, 2010 (GLOBE NEWSWIRE) — Myriad Pharmaceuticals, Inc. (Nasdaq:MYRX) today announced the presentation of clinical data from two separate Phase 2a combination drug studies of AzixaTM (MPC-6827, verubulin) at the American Society of Clinical Oncology 2010 Annual Meeting in Chicago, IL. Results from studies in both recurrent glioblastoma multiforme (GBM) and stage 4 metastatic melanoma demonstrated that Azixa, in combination with standard treatments, resulted in durable responses with no added toxicity compared with chemotherapy alone.
Read More >> http://yhoo.it/bwIhcP ——————————————————————— Company: Rosetta Genomics, Ltd. (Nasdaq: ROSG) http://bit.ly/bdiOLI Data Presented at ASCO 2010 by M. D. Anderson Researchers Demonstrate the ability of miRview mets to Identify the Most Likely Origin of Metastases in Cancer of Unknown Primary REHOVOT, Israel & PHILADELPHIA–(BUSINESS WIRE)–Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostic tests, announces new, interim data from an ongoing prospective study conducted in collaboration with researchers from the University of Texas, M. D. Anderson Comprehensive Cancer Center (MDACC), and presented at ASCO 2010. The ongoing study is designed to examine the ability of miRview mets to identify the most likely primary origin of metastases in patients with cancer of unknown primary (CUP). This was achieved by correlating the predicted primary origin assigned by miRview mets with the comprehensive diagnostic work-up conducted at MDACC, which included surgical pathology, laboratory tests, imaging and a treatment-response follow-up.
Read More >> http://yhoo.it/ay21CB —————————————————————– Company: Aeterna Zentaris Inc. (Nasdaq: AEZS) http://bit.ly/9tfQKo Aeterna Zentaris Announces Phase 1 Data of Single Agent Perifosine in the Treatment of Recurrent Pediatric Solid Tumors, Including Patients with Advanced Brain Tumors and Neuroblastoma QU=C9BEC CITY, June 7 /PRNewswire-FirstCall/ – Aeterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS), (the “Company”) a late
-stage drug development company specialized in oncology and endocrine therapy, today announced that Phase 1 data of perifosine (KRX-0401) in recurrent pediatric solid tumors was presented yesterday in the pediatric solid tumor poster discussion session held at the 46th Annual Meeting of the American Society of Clinical Oncology (ASCO) taking place in Chicago. Perifosine is the Company`s novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase (PI3K) pathway. This study, conducted by the Memorial Sloan-Kettering Cancer Center pediatric group, marks the first time that perifosine has been administered in a pediatric patient setting. Perifosine is also currently in Phase 3 trials in multiple myeloma and colorectal cancer, as well as in Phase 2 trials for multiple types of cancer.
Read More >> http://yhoo.it/daFvWr —————————————————————————– Company: Javelin Pharmaceuticals, Inc. (NYSE Amex: JAV) http://bit.ly/9eZrcl Javelin Receives Notice from Hospira of Funding of Loan CAMBRIDGE, Mass.–(BUSINESS WIRE)–Javelin Pharmaceuticals, Inc. (NYSE — Amex: JAV) (“Javelin”) today announced that on June 4, 2010, Javelin received notice from Hospira, Inc. (“Hospira”) that Hospira will fund a $2 million loan to Javelin on June 10, 2010 under the existing loan agreement between Javelin and Hospira.
Read More >> http://yhoo.it/bM5e7p —————- MarketNews —————- By Pedro Nicolaci da Costa: Reuters Increasingly hawkish Fed ponders raising rates ATLANTA (Reuters) – Three top Federal Reserve officials said on Thursday it may soon be time to begin raising interest rates as the economic recovery in the United States gathers momentum, despite persistently high unemployment.
Thomas Hoenig, president of the Kansas City Fed, argued the U.S. central bank should raise benchmark borrowing costs from near zero to 1 percent by the end of summer.
The head of the Atlanta Fed, Dennis Lockhart, said policymakers should soon begin thinking about tightening monetary policy, though he stopped short of calling for an imminent move.
Read More >> http://yhoo.it/9Id652 ——————————————– By Annalyn Censky: Staff Reporter Euro plummets below $1.20 The euro fell to a fresh four-year low below $1.20 Friday, as investors cast fresh doubts on the European debt crisis and a global recovery after gloomy economic statements out of Hungary and a disappointing U.S. jobs report.
What prices are doing: The euro slipped as much as 1.6% against the dollar to $1.19721, a fresh four-year low for Europe`s shared currency. It was the second day in a week that the euro`s losses surpassed the four-year low in intra-day trading.
Meanwhile, the dollar fell 1.27% against the Japanese yen to =A591.53.
Read More >> http://yhoo.it/cPUMQN ———————————– Research and Commentary ———————————– Who Could Gobble Up a Hobbled BP http://yhoo.it/aPsxJs ————- Disclaimer ————- You are receiving this e-mail because you either opted into to our mailing list at smallcapvoice.com or at one of our Money Show exhibits. You may opt out at any time by clicking on the Safe
Related posts:
- SC Daily- TTCS Issues News
- SC Daily- Another Day and More Great news from TTCS and MFLI
- SC Daily- TOOT Adds Upscale Restaurant, MFLI Adds Celebrities
- SC Daily- TTCS Trades Nicely and MFLI Announces Reality Shows
- SC Daily- BLQN Is Smart Green Play. TTCS Issues News